NCT00114920View on ClinicalTrials.gov

Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

March 31, 2004

Conditions
Warts
Interventions
DRUG

Resiquimod

Trial Locations (1)

47713

Welborn Clinic, Evansville

Sponsors
All Listed Sponsors
lead

Graceway Pharmaceuticals, LLC

INDUSTRY